Bright Minds Biosciences Stock Quote DRUG - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.16

Bid

1.12

Ask

1.31

Volume

43,069

1.1501 Day's Range 1.30

0.93 52 Week Range 2.39

Market Cap

5.178M

Previous Close

1.25

Open

1.30

Last Trade

1.27

Last Trade Time

Financial Volume

$ 52,840

VWAP

1.2269

Average Volume (3m)

116,199

Shares Outstanding

4,463,837

Dividend Yield

PE Ratio

-0.75

Earnings Per Share (EPS)

-1.65

Revenue

Net Profit

-7.37M

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disord... Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.brightmindsbio.com

Headquarters

Vancouver, British Columbia, Can

Founded

Bright Minds Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DRUG. The last closing price for Bright Minds Biosciences was $1.25. Over the last year, Bright Minds Biosciences shares have traded in a share price range of $ 0.93 to $ 2.39.

Bright Minds Biosciences currently has 4,463,837 shares outstanding. The market capitalization of Bright Minds Biosciences is $5.58 million. Bright Minds Biosciences has a price to earnings ratio (PE ratio) of -0.75.

Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th

Bright Minds Biosciences announced the initiation of Phase 2 clinical trial of BMB-101 in a group of drug-resistant epilepsies and will discuss the details of the BREAKTHROUGH clinical trial on...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy PR Newswire NEW YORK, Sept. 12, 2024 Bright...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.07	-5.69105691057	1.23	1.4	1.1501	29684	1.25702027	CS
4	0.13	12.6213592233	1.03	1.75	0.99	290654	1.32957973	CS
12	0.08	7.40740740741	1.08	1.75	0.9305	116199	1.296239	CS
26	-0.1	-7.93650793651	1.26	1.75	0.93	61511	1.27738154	CS
52	-0.49	-29.696969697	1.65	2.39	0.93	44635	1.3990256	CS
156	-43.59	-97.4078212291	44.75	44.75	0.93	1296683	10.29073674	CS
260	-43.59	-97.4078212291	44.75	44.75	0.93	1296683	10.29073674	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GSIWGarden Stage Ltd	$ 8.17 (259.91%)	70.64M
ZEOZeo Energy Corporation	$ 2.5995 (128.03%)	59.98M
TBIOTelesis Bio Inc	$ 2.9201 (114.71%)	53.74M
NCINeo Concept International Group Holdings Ltd	$ 0.84 (71.43%)	12.68M
VEROVenus Concept Inc	$ 0.8475 (68.66%)	20.56M
HAOHaoxi Health Technology Ltd	$ 0.83 (-72.33%)	7.93M
PGNYProgyny Inc	$ 16.465 (-32.63%)	17.44M
NUZENuZee Inc	$ 0.6998 (-32.06%)	14.04M
RGFReal Good Food Company Inc	$ 0.308 (-28.37%)	360.79k
ALGSAligos Therapeutics Inc	$ 10.18 (-28.11%)	839.92k
NVDANVIDIA Corporation	$ 117.87 (3.97%)	293.54M
SQQQProShares UltraPro Short QQQ	$ 7.76 (-7.62%)	222.56M
HOLOMicroCloud Hologram Inc	$ 0.2328 (15.08%)	120.19M
MAXNMaxeon Solar Technologies Ltd	$ 0.1034 (13.75%)	105.03M
TSLATesla Inc	$ 243.92 (7.36%)	102.7M